Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMahidol University
About this trial
This is an observational study among approximately 160 end-stage renal disease patients on renal replacement therapy and post-living donor or deceased donor kidney transplant recipients. Investigators aim to assess the proportion of positive IGRA associated with symptom development, sputum Xpert MTB/RIF assay, and chest radiograph to define latent TB infection and subclinical TB among ESKD and renal transplant patients.
Eligibility criteria
Qualifiers
End-stage renal disease on renal replacement therapy (hemodialysis or peritoneal dialysis) or status-post-living donor or deceased donor kidney transplantation
Aged more than or equal 18 years
Disqualifiers
Positive PPD test or a previously documented positive PPD
Active pulmonary or extrapulmonary tuberculosis
Trial design
Treatments tested in this trial
- Not listed
Trial groups
160 Participants
are grouped into 1 trial groupSponsors and collaborators
Mahidol University
Lead sponsor
National Research Council of Thailand
Collaborator
Source ClinicalTrials.gov